Nevirapine Clarithromycin 641

Clinical Bottom Line
Minimal data to guide interaction: weigh risks and benefits when using this combination
Drug 1
Drug 1 dose
200 mg daily x 14 days; 200 mg BID x 14 days
Drug 2 dose
500 mg BID
Drug 2 effect

Clarithromycin AUC decreased 31%; Cmax decreased 23%; Cmin decreased 56%; 14-hydroxy clarithromycin AUC increased 42%, Cmax increased 47%

Clinical Effects

Decreased clarithromycin effects but increased metabolite concentrations

Management

Consider using alternative agents such as Azithromycin

Import ID
641